Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Corbion N.V. Capital/Financing Update 2007

Sep 27, 2007

3826_iss_2007-09-26_fe3b97f5-fea5-48f1-98c8-674b330d73b0.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

CSM nv Corporate Communications

P.O. Box 349 1000 AH Amsterdam The Netherlands

Nienoord 13 1112 XE Diemen

T +31 (0)20 590 62 16 F +31 (0)20 590 62 17 E [email protected]

Press Release

PURAC STRATEGIC REVIEW RESULTS IN RESTRUCTURING OPERATION

Diemen, the Netherlands, 26 September 2007 – CSM subsidiary PURAC intends to restructure its operations by integrating the new production plant in Thailand into the overall production capacity and by discontinuing lactic acid production in the Netherlands and Spain as a result of a strategic review. Furthermore, in the Netherlands, the production of lactitol in Gorinchem will be closed down and the manufacturing plant in Ter Apelkanaal will be sold. Overall 160 jobs are affected. The new manufacturing footprint, which will be implemented in the course of 2008, will substantially improve the results of PURAC. The asset write down is expected to range between € 40 million and € 55 million depending on the sale proceeds.

The lactic acid market is developing into a highly competitive market in which production capacity needs to be used in the most efficient way. Therefore, Purac's lactic acid manufacturing will be discontinued in the Netherlands (Gorinchem) and Spain (Montmelo). It is no longer economically feasible to produce lactic acid in those plants. In the future, all lactic acid will be produced in the PURAC factories in Thailand (Rayong), Brazil (Campos) and the US (Blair).

The lactic acid factory in Gorinchem will specialize in the production of lactic acid derivatives, in which production of lactitol is no longer considered strategic and will be discontinued. The lactic acid factory in Montmelo will gradually be transformed into a new D (-) and lactide plant to meet the increasing demand in PLA (Poly Lactic Acid) markets in line with the recently announced PLA innovations for the bio-plastics industry.

The production of gluconic acid and gluconates is no longer considered strategic. PURAC recently sold its gluconic acid business in Janesville (US) and now intends to sell the manufacturing plant in Ter Apelkanaal.

The unions and works councils have been informed and will be counseled. Compulsory dismissals can not be excluded.

Fabrizio Rampinelli, Managing Director of PURAC: "The new manufacturing footprint will align the structure and capacity of the PURAC organization with market potential and future demand. The new organization will result in higher levels of efficiency necessary to improve our results and will allow us to increase our flexibility towards our customers."

-----------------------------------------------------------------------------------------------------------------------

For more information, please contact:

Press: Mirko Creyghton, Director Corporate Communications, tel. +31 (0)20 5906216 / cell phone +31 6 53527622 Analysts: Ian Blackford, Investor Relations Manager, tel. +31 (0)20 5906349 / cell phone +44 (0)7767 227506

Background information

About PURAC

PURAC is global market leader in lactic acid, has 70 years of experience and owns a broad portfolio of patents. PURAC has state-of-the-art lactic acid plants located in areas with favourable carbohydrate feedstock. A new lactic acid plant in Thailand will be operational early 2008. PURAC is a CSM company with annual sales of € 295 million and a workforce of around 1000 employees. PURAC operates in Europe, North America, Brazil and Asia. For more information: www.purac.com.

About CSM

CSM is the largest supplier of bakery products worldwide and is global market leader in lactic acid and lactic acid derivatives. CSM produces and distributes an extensive range of bakery products and ingredients for artisan and industrial bakeries and for out-of-home markets. It also produces a variety of lactic acid applications for the food, chemical and pharmaceutical industries. CSM operates in business-to-business markets throughout Europe, North America, South America and Asia, generates annual sales of € 2.4 billion and has a workforce of around 8,600 employees in 22 countries. CSM is listed on Euronext Amsterdam. For more information: www.csm.nl.